Seer develops the Proteograph® Product Suite, an integrated platform combining proprietary engineered nanoparticles, automation instruments, and cloud-based data analytics software to deliver deep, rapid, and unbiased proteomics—the large-scale analysis of all proteins expressed by cells and tissues. The company's technology solves a fundamental challenge in protein research by eliminating the traditional trade-off between comprehensive analysis depth and processing throughput, enabling peptide-level detection of thousands of proteins in complex samples like blood plasma without requiring predefined binding epitopes. Seer serves academic institutions, biopharmaceutical companies, biobanks, and clinical research organizations across the global proteomics market through direct sales, service-based access, and partnerships with service providers and instrument manufacturers, generating revenue primarily from consumable assay kits alongside instrument sales, software licensing, and service fees.